| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |